Z Squared Inc. ZSQR

FY2025 · ended Dec 31, 2025 · Revenue $1.36M · Filed Mar 19, 2026

Z Squared Inc. (ZSQR) files with the SEC under industry code 6199, Finance Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.4 million and a net loss of $11.9 million.

Revenue (TTM)
$2.95M
Net income (TTM)
$-25.71M
-453.7% vs year-ago TTM
Operating cash flow (TTM)
$-8.81M
-164.5% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-4.51
-429.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
6.22M
-82.8% vs prior year
Net cash
$6.18M
FY 2025
Operating margin
-910.8%
FY 2026

Company profile

Industry
Finance Services (SIC 6199)
Listed as
ZSQR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Fort Lauderdale, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1759186
Former names
Coeptis Therapeutics Holdings, Inc. (until Apr 28, 2026); Bull Horn Holdings Corp. (until Oct 28, 2022)

Other Finance Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$1.4M
$0
$0
$0
—
Operating income
-$13.0M
-$10.1M
-$21.5M
-$34.2M
-$14.0M
Net income
-$11.9M
-$10.7M
-$21.3M
-$37.6M
-$13.4M
Diluted EPS
-$2.81
-$5.56
-$16.56
-$2.63
—
Operating cash flow
-$8.6M
-$6.6M
-$7.2M
-$3.9M
-$4.5M
Total assets
$16.2M
$8.9M
$4.6M
$7.9M
$6.8M
Total liabilities
$2.1M
$5.0M
$3.8M
$3.5M
$4.4M
Stockholders' equity
$13.6M
$3.4M
$813,964
$4.5M
$2.4M
Cash and investments
$6.4M
$532,885
$1.5M
$3.8M
$77.9M
Total debt
$168,875
$61,180
$1.2M
$206,341
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Nov 3, 2026 Nov 3, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
Sep 14, 2026 Sep 8, 2026
8-K Current report
Bylaw or fiscal year change
Sep 10, 2026 Sep 9, 2026
8-K Current report
Officer or director change
Aug 26, 2026 Aug 24, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
Aug 4, 2026 Jul 29, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.